IZ Trading: Thermogenesis - der Biotec from Nasdaq

tja, IZ will performance sehen, und zwar von allen depotanten,
also arxes raus (KK 22,20, VK 21,80) und

Thermogenesis = KOOL.NASDAQSM rein:

Story:
Ist ein Zulieferer für Biotecs, der langsam wieder entdeckt wird...
weitere Infos folgen...
sollte bald sein ATH überwinden...

Gruß
IZ


 

 

short and old:Thermogenesis hires Warburg Dillon as market adviser
                   Officials for Thermogenesis Corp. (Nasdaq: KOOL) of Rancho Cordova say it has hired Warburg Dillon Read of New
                   York City to provide advisory and investment banking services, to help the company enhance its value. "The
                   development of our most important biomaterial product -- the CryoSeal Fibrin Sealant System -- is near
                   completion, and Warburg's counsel should help us to realize the substantial value to shareholders that this and our
                   hematopoietic stem cell technologies deserve," said President and CEO Philip Coelho. Thermogenesis pioneered the
                   creation of thermodynamic devices for processing and freezing blood and other biological substances.

News:
http://biz.yahoo.com/n/k/kool.html

latest:
THERMOGENESIS CORP. Receives $540,000 Order for Seven Ultra Rapid
Plasma Freezers From Aventis Bio-Services, Inc.

RANCHO CORDOVA, Calif.--(BW HealthWire)--Aug. 28, 2000-- THERMOGENESIS CORP. (Nasdaq:KOOL -
news) announced that Aventis Bio-Services, Inc. (formerly Centeon Bio-Services, Inc.) placed an order for seven
MP2000 Plasma Freezers which freeze one-litre bottles of plasma five times faster than conventional air blast freezers. Rapidly frozen plasma
retains higher levels of the Factor VIII protein used for the treatment of hemophilia. The $540,000 order includes the seven freezers, service
contract and other accessories, which will be installed in seven of the 47 plasma collection centers recently acquired by Aventis from Seramed.
THERMOGENESIS CORP. anticipates shipping all seven MP2000 Freezers by the end of the calendar year.

THERMOGENESIS CORP. anticipates additional MP2000 Freezers will be installed in the remaining 40 newly acquired plasma collection centers
in order to standardize the production process with the existing Aventis plasma collection centers. Aventis has purchased 86 of the Ultra Rapid
Freezers for 43 of their plasma collection centers.

Dr. James Godsey, president and COO of THERMOGENESIS CORP. commented, ``... we were pleased to see Aventis continue their practice of
exclusively using only THERMOGENESIS CORP.'s Ultra Rapid Plasma Freezers in their source plasma collection facilities and that the use
continues to grow as their network of plasma centers grows through acquisition of existing centers. Aventis is the global leader in the production of
the highest quality plasma proteins.''

About Aventis Bio-Services, Inc.

Aventis Bio-Services, Inc. is a wholly owned subsidiary of Aventis, the joint venture combining the plasma operations of Rhone-Poulenc Rorer
and Hoechst AG, and is the world's largest fully integrated plasma collection company. Aventis is the global leader in the plasma protein industry,
producing a comprehensive line of therapies that include coagulation therapies for the treatment of hemophilia, immunoglobulins for the
prevention and treatment of immune disorders, and plasma expanders for the treatment of a variety of conditions such as shock, burns and
circulatory disorders.

About THERMOGENESIS CORP.

THERMOGENESIS CORP. has been a pioneer in designing, manufacturing and distributing equipment to collect, cryopreserve and archive highly
sensitive blood products and biological tissue for more than 10 years.

The statements contained in this release which are not historical facts are forward-looking statements that are subject to risks and uncertainties
that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain
delays beyond the company's control with respect to market acceptance of new technologies and products, delays in testing and evaluation of
products, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.

 

 

 

 

 

www.island.com/BookViewer/javaversion.htm
schliesslich sind die ja schon seit drei Tagen so hochgeschossen  

ich warte auf noch bessere einstiegschancen, denn ich kann schwer abschätzen
inwieweit, der n-tv-push zu dem hipe beigetragen hat.
außerdem stört mich etwas das geringe volumen.
trotzdem halte ich den wert für LONG und INTRADAY sehr inetressant.


gruß
IZ